- Home
- BWMX vs SAGE Comparison
BWMX vs SAGE Comparison
Compare BWMX & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWMX
- SAGE
- Stock Information
- Founded
- BWMX 1995
- SAGE 2010
- Country
- BWMX Mexico
- SAGE United States
- Employees
- BWMX N/A
- SAGE N/A
- Industry
- BWMX Catalog/Specialty Distribution
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- BWMX Consumer Discretionary
- SAGE Health Care
- Exchange
- BWMX Nasdaq
- SAGE Nasdaq
- Market Cap
- BWMX 354.5M
- SAGE 413.9M
- IPO Year
- BWMX N/A
- SAGE 2014
- Fundamental
- Price
- BWMX $8.86
- SAGE $9.25
- Analyst Decision
- BWMX Strong Buy
- SAGE Hold
- Analyst Count
- BWMX 1
- SAGE 18
- Target Price
- BWMX $22.50
- SAGE $10.06
- AVG Volume (30 Days)
- BWMX 55.8K
- SAGE 2.5M
- Earning Date
- BWMX 07-24-2025
- SAGE 07-30-2025
- Dividend Yield
- BWMX 16.07%
- SAGE N/A
- EPS Growth
- BWMX N/A
- SAGE N/A
- EPS
- BWMX 0.74
- SAGE N/A
- Revenue
- BWMX $684,841,453.00
- SAGE $47,404,000.00
- Revenue This Year
- BWMX $4.90
- SAGE $102.21
- Revenue Next Year
- BWMX $6.07
- SAGE $43.01
- P/E Ratio
- BWMX $11.48
- SAGE N/A
- Revenue Growth
- BWMX 4.87
- SAGE N/A
- 52 Week Low
- BWMX $7.00
- SAGE $4.62
- 52 Week High
- BWMX $16.04
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- BWMX 55.02
- SAGE 77.14
- Support Level
- BWMX $8.04
- SAGE $6.44
- Resistance Level
- BWMX $9.15
- SAGE $9.33
- Average True Range (ATR)
- BWMX 0.37
- SAGE 0.24
- MACD
- BWMX 0.16
- SAGE 0.26
- Stochastic Oscillator
- BWMX 80.67
- SAGE 97.23
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.